日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Role of Radiotherapy in the Era of Novel Immune-Based Treatment Strategies for Multiple Myeloma

放射疗法在多发性骨髓瘤新型免疫治疗策略时代的作用

Schlusemann, Tom; Shumilov, Evgenii; Reinartz, Gabriele; Steike, David Rene; Lohmann, Sebastian; Gravemeyer, Stefan; Stelljes, Matthias; Lenz, Georg; Eich, Hans Theodor; Oertel, Michael

Total neoadjuvant therapy for locally advanced rectal cancer: barriers to implementation in real-world practice

局部晚期直肠癌新辅助治疗:实际应用中的障碍

Steike, David Rene; Pepper, Niklas Benedikt; Gravemeyer, Stefan; Bremer, Anne; Glasbrenner, Bernhard; Brüwer, Matthias; Pascher, Andreas; Domagk, Dirk; Biermann, Lothar; Lenz, Philipp; Eich, Hans Theodor; Reinartz, Gabriele

Immune reconstitution in AML and MDS patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) with treosulfan- or TBI-based conditioning

接受基于曲奥舒凡或全身照射预处理的异基因造血干细胞移植(allo-HCT)的急性髓系白血病(AML)和骨髓增生异常综合征(MDS)患者的免疫重建

Kolloch, Lina; Berning, Philipp; Albring, Jörn C; Ronnacker, Julian; Reicherts, Christian; Call, Simon; Marx, Julia; Floeth, Matthias; Esseling, Eva; Eich, Hans Theodor; Schliemann, Christoph; Mikesch, Jan-Henrik; Lenz, Georg; Stelljes, Matthias

Prognostic marker Musashi-2 modulates DNA damage response and radioresistance in diffuse large B-cell lymphoma

预后标志物 Musashi-2 调节弥漫性大B细胞淋巴瘤的DNA损伤反应和放射抗性

Habig, Timo; Reichstein, Lasse; Brücksken, Kathrin A; Sicking, Mark; Labisch, Jan; Oertel, Michael; Korsching, Eberhard; Lenz, Georg; Hailfinger, Stephan; Greve, Burkhard; Troschel, Fabian M; Eich, Hans Theodor

Blood group O attributes to prolonged progression-free survival, overall survival, and 5-year survival in isocitrate dehydrogenase-wildtype glioblastoma patients with MGMT promoter methylation

型血与异柠檬酸脱氢酶野生型胶质母细胞瘤患者 MGMT 启动子甲基化相关的无进展生存期、总生存期和 5 年生存期延长有关。

Wiewrodt, Rainer; Kloss, Maren; Jost-Engl, Johanna; Troschel, Fabian M; Troschel, Benjamin O; Eich, Hans Theodor; Thomas, Christian; Lemcke, Lars; Stummer, Walter; Wiewrodt, Dorothee

Practical recommendations for therapy and monitoring of mogamulizumab patients in Germany

德国莫加莫利珠单抗治疗和监测患者的实用建议

Assaf, Chalid; Booken, Nina; Dippel, Edgar; Dobos, Gabor; Eich, Hans-Theodor; Klemke, Claus-Detlev; Mitteldorf, Christina; Nicolay, Jan P; Theurich, Sebastian; Wobser, Marion; Stadler, Rudolf

Low-dose total skin electron beam therapy in erythrodermic mycosis fungoides and Sézary syndrome: Results From the Prospective S-MISR Study

低剂量全皮肤电子束疗法治疗红皮病型蕈样肉芽肿和塞扎里综合征:前瞻性 S-MISR 研究的结果

Elsayad, Khaled; Kandler, Christian; Siats, Jan Jakob; Pepper, Niklas; Danzer, Moritz Fabian; Dobos, Gabor; Livingstone, Elisabeth; Melchers, Susanne; Kleemann, Johannes; Hyun, Julia; Pföhler, Claudia; von den Driesch, Peter; Nicolay, Jan P; Stadler, Rudolf; Eich, Hans Theodor

Impact of comorbidities on treatment management and prognosis in patients with anaplastic thyroid cancer (ATC)

合并症对间变性甲状腺癌(ATC)患者治疗管理和预后的影响

Augustin, Teresa; Oliinyk, Dmytro; Haderlein, Marlen; Frei, Charlotte; Jacob, Julia; Medenwald, Daniel; Trommer, Maike; Mäurer, Matthias; Drozdz, Sonia; Rühle, Alexander; Grosu, Anca-Ligia; Nicolay, Nils Henrik; Waltenberger, Maria; Combs, Stephanie E; Löser, Anastassia; Oertel, Michael; Eich, Hans Theodor; Janssen, Stefan; Rauch, Josefine; Gurtner, Ralph; Renollet, Robert; Spitzweg, Christine; Vordermark, Dirk; Belka, Claus; Käsmann, Lukas

Risk factors for treatment-related sensorineural hearing loss and hearing aid use in medulloblastoma patients: an observational cohort study

髓母细胞瘤患者治疗相关性感觉神经性听力损失及助听器使用风险因素:一项观察性队列研究

Troschel, Fabian M; Steike, David Rene; Roers, Julian; Kittel, Christopher; Siats, Jan; Parfitt, Ross; Hesping, Amélie E; Am Zehnhoff-Dinnesen, Antoinette; Neumann, Katrin; Eich, Hans Theodor; Scobioala, Sergiu

Impact of pretreatment PET/MRI on radiooncologic target delineation in Hodgkin's lymphoma: a case series

治疗前PET/MRI对霍奇金淋巴瘤放射肿瘤靶区勾画的影响:病例系列研究

Kröger, Kai; Lohmann, Sebastian; Oertel, Michael; Borchmann, Peter; Kerkhoff, Andrea; Lenz, Georg; Stegger, Lars; Eich, Hans Theodor